SPINAZZE; Patrick Gianpietro
Patent Applications and Registrations
Patent applications and USPTO patent grants for SPINAZZE; Patrick Gianpietro.The latest application filed is for "disubstituted pyrazole compounds".
- SPINAZZE; Patrick Gianpietro - Avon IN
- Spinazze; Patrick Gianpietro - Fishers IN
| Patent | Date |
|---|---|
| Disubstituted Pyrazole Compounds App 20220017496 - COATES; David Andrew ; et al. | 2022-01-20 |
| Disubstituted pyrazole compounds Grant 11,124,500 - Coates , et al. September 21, 2 | 2021-09-21 |
| Disubstituted Pyrazole Compounds App 20200392118 - COATES; David Andrew ; et al. | 2020-12-17 |
| 6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists Grant 9,469,632 - Gardinier , et al. October 18, 2 | 2016-10-18 |
| 6-substituted-3h-1,3-benzothiazol-2-one Compounds As Tarp-gamma 8 Dependent Ampa Receptor Antagonists App 20150344468 - GARDINIER; Kevin Matthew ; et al. | 2015-12-03 |
| 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists Grant 8,202,873 - Badescu , et al. June 19, 2 | 2012-06-19 |
| MCH receptor antagonists Grant 8,101,764 - Amegadzie , et al. January 24, 2 | 2012-01-24 |
| 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl Pyrazines And Pyridines And 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl Pyridines As 5-ht7 Receptor Antagonists App 20100120785 - Badescu; Valentina O. ; et al. | 2010-05-13 |
| Novel Mch Receptor Antagonists App 20100016350 - Amegadzie; Albert Kudzovi ; et al. | 2010-01-21 |
| Piperazine substituted aryl benzodiazepines Grant 7,384,934 - Aicher , et al. June 10, 2 | 2008-06-10 |
| .beta.3 adrenergic agonists Grant 7,208,505 - Sall , et al. April 24, 2 | 2007-04-24 |
| Indole derivatives for the treatment of depression and anxiety Grant 7,144,898 - Hansen , et al. December 5, 2 | 2006-12-05 |
| 3-substituted oxindole .beta.3 agonists Grant 7,087,635 - Sall , et al. August 8, 2 | 2006-08-08 |
| Piperazine substituted aryl benzodiazepines App 20060084643 - Aicher; Thomas Daniel ; et al. | 2006-04-20 |
| 3-Substituted oxindole beta3 agonists App 20050159473 - Sall, Daniel Jon ; et al. | 2005-07-21 |
| 3-substituted oxindole .beta.-3 agonists Grant 6,911,463 - Sall , et al. June 28, 2 | 2005-06-28 |
| Beta 3 adrenergic agonists App 20050080110 - Sall, Daniel Jon ; et al. | 2005-04-14 |
| Benzofuran derivatives Grant 6,844,344 - He , et al. January 18, 2 | 2005-01-18 |
| Tropane linked benzofuran derivatives Grant 6,835,733 - He , et al. December 28, 2 | 2004-12-28 |
| 3-substituted oxindole beta-3 agonists App 20040242668 - Sall, Daniel Jon ; et al. | 2004-12-02 |
| Piperidines derivatives and their use as serotonin receptor antagonists Grant 6,784,180 - He , et al. August 31, 2 | 2004-08-31 |
| Indole derivatives for the treatment of depression and anxiety App 20040006229 - Hansen, Marvin Martin ; et al. | 2004-01-08 |
| Benzofuran derivatives App 20030232833 - He, John Xiaoqiang ; et al. | 2003-12-18 |
| Piperidines derivatives and their use as serotonin receptor antagonists App 20030225281 - He, John Xiaoqiang ; et al. | 2003-12-04 |
| Benzofuran derivatives App 20030130513 - He, John Xiaoqiang ; et al. | 2003-07-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 